Incidence of Venous Thromboembolism in Hospitalized Patients with COVID-19

Background: COVID-19 triggers widespread blood clotting. Studies show high D-dimer concentrations (not less than 0.5 milligrams per liter) in nearly half of cases, with frequent mild platelet drops and clotting time increases.
Aim: To assess the occurrence of venous thromboembolism (VTE) and its correlation with illness degree and death among hospitalized cases with confirmed coronavirus disease 2019 (covid-19) infection.
Patient and methods: History taking, CT of the chest and laboratory examination involving renal and hepatic function tests, complete blood count, C-reactive protein (CRP), serum ferritin, and D-dimer have been performed.
Results: A total of 123 hospitalized COVID-19 cases have been enrolled, the mean age of the examined group was 59±15.3 years; 59.3% of cases were males, while 40.7% were females; the majority were non-smokers (65%), while 23.6% were smokers; 64.2% of patients had moderate disease, while only 13% had critical disease; the majority of patients survived (90.2%); and 7.3% of the participants developed venous thromboembolism.
Conclusion: VTE was observed in 7.3% of COVID-19 patients and has been correlated with increased disease degree, inflammation, longer hospitalization, and higher mortality. Early detection and preventive strategies are essential to improve outcomes.